Proportion of isolates with decreased susceptibility or resistance in Singapore

Singapore: Proportion of isolates with decreased susceptibility or resistance was 2.2 in 2020. ◆ Volatile

Latest (2020)
2.2
Change on year
up 46.7%
World rank
6th
of 52 countries
All-time high
6.88
in 2011
All-time low
0
in 2010
Years of data
11
2009–2020

Proportion of isolates with decreased susceptibility or resistance in Singapore, 2009–2020

02462009201420202009: 1.22010: 02011: 6.92012: 02013: 1.82014: 02015: 02016: 6.52017: 5.22018: 1.52020: 2.2

Source: World Health Organization, Global Health Observatory.

Analysis

Singapore recorded 2.2 for proportion of isolates with decreased susceptibility or resistance in 2020.

The figure is up 46.7% on the previous year.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in Singapore peaked at 6.88 in 2011 and was at its lowest, 0, in 2010.

Singapore ranks 6th of 52 countries on this measure, in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in Singapore, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP in Singapore, 2009 to 2020.
Year Value Change
2009 1.25
2010 0 -100.0%
2011 6.88
2012 0 -100.0%
2013 1.82
2014 0 -100.0%
2015 0
2016 6.52
2017 5.17 -20.7%
2018 1.5 -71.0%
2020 2.2 +46.7%

Singapore compared with similar countries

  • Singapore's 2.2 is above the median for East Asia & Pacific, which is 0.7752, 2.8× the median. (11 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 1.25 1.25 1.25 1
2010s 2.43 0 6.88 9
2020s 2.2 2.2 2.2 1

Countries ranked near Singapore

  1. 3 Malaysia 6.8 compare
  2. 4 Viet Nam 6.09 compare
  3. 5 Japan 3.7 compare
  4. 7 Canada 1.4 compare
  5. 8 Bhutan 1 compare
  6. 9 Mongolia 0.7752 compare

See the full ranking of 52 places →

More health data for Singapore

All data for Singapore →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in Singapore?
Proportion of isolates with decreased susceptibility or resistance in Singapore was 2.2 in 2020, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Singapore?
The highest recorded value was 6.88 in 2011.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Singapore?
The lowest recorded value was 0 in 2010.
How does Singapore rank for proportion of isolates with decreased susceptibility or resistance?
Singapore ranks 6th out of 52 countries with data for 2020.
Where does this Singapore data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in Singapore. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/singapore/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/singapore/">Proportion of isolates with decreased susceptibility or resistance in Singapore</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
52 places, 454 data points, 2009–2020
Last refreshed